clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Gram-Negative Bacterial Infections D016905 16 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Meningitis, Bacterial D016920 6 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
IgA Deficiency D017098 2 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Dermatitis, Phototoxic D017484 4 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Cutaneous Fistula D017577 1 associated lipids
Kleine-Levin Syndrome D017593 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Cardiovascular Abnormalities D018376 2 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Soft Tissue Infections D018461 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cryptogenic Organizing Pneumonia D018549 3 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Tooth, Nonvital D019553 2 associated lipids
alpha 1-Antitrypsin Deficiency D019896 3 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Epilepsy, Partial, Motor D020938 1 associated lipids
Chlamydophila Infections D023521 4 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Renal Insufficiency D051437 8 associated lipids
Immune Reconstitution Inflammatory Syndrome D054019 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Extensively Drug-Resistant Tuberculosis D054908 1 associated lipids
Leprosy, Paucibacillary D056005 2 associated lipids
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Sacroiliitis D058566 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Sato T et al. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. 2011 Antimicrob. Agents Chemother. pmid:21220530
Pakhale S et al. Optimal management of severe/refractory asthma. 2011 Clin Med Insights Circ Respir Pulm Med pmid:21912491
Khoshnegah J et al. The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection. 2011 J. Feline Med. Surg. pmid:21144784
Chauty A et al. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. 2011 Clin. Infect. Dis. pmid:21148526
Castro-Silva AN et al. Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment. 2011 Transpl Infect Dis pmid:20534038
Tanabe T et al. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21642590
Kumar S et al. Multifocal keloids associated with Mycobacterium fortuitum following intralesional steroid therapy. 2011 J Lab Physicians pmid:22219571
Tselios K et al. Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report. 2011 BMC Infect. Dis. pmid:22206235
Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). 2011 J. Antimicrob. Chemother. pmid:22096065
Lubell Y et al. Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics. 2011 Trop. Med. Int. Health pmid:21740488
Ma S et al. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains. 2011 Eur J Med Chem pmid:21159410
Furuta T et al. Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection. 2011 Intern. Med. pmid:21372444
Niioka T Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. 2011 Yakugaku Zasshi pmid:21372537
Zhang T et al. [Preparation and evaluation of enteric-coated and taste masking clarithromycin granules]. 2011 Yao Xue Xue Bao pmid:22375429
Sugimoto T and Tanikawa T Synthesis and antibacterial activity of a novel class of 15-membered macrolide antibiotics, "11a-azalides". 2011 ACS Med Chem Lett pmid:24900300
König J et al. Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. 2011 Drug Metab. Dispos. pmid:21430235
Bugdaci MS et al. The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine. 2011 Helicobacter pmid:21435090
Hsu PI et al. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? 2011 Helicobacter pmid:21435093
Kim EY et al. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease. 2011 Korean J. Intern. Med. pmid:21437163
Hsieh CJ et al. Facial cellulitis because of Aggregatibacter (Actinobacillus) actinomycetemcomitans and Capnocytophaga species in an immunocompetent patient. 2011 J Microbiol Immunol Infect pmid:21439519
Shcherbakov PL et al. [Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract]. 2011 Eksp Klin Gastroenterol pmid:22364005
Ishikawa M et al. Structural changes in the lacrimal sac epithelium and associated lymphoid tissue during experimental dacryocystitis. 2011 Clin Ophthalmol pmid:22125403
Mazzoleni LE et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. 2011 Arch. Intern. Med. pmid:22123802
Hoffmann K et al. Antibiotic resistance in primary care in Austria - a systematic review of scientific and grey literature. 2011 BMC Infect. Dis. pmid:22123085
van Hoek AH et al. Acquired antibiotic resistance genes: an overview. 2011 Front Microbiol pmid:22046172
McNabe M et al. Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials. 2011 Clin. Microbiol. Infect. pmid:20636426
Yamamoto E et al. [Case of Fusobacterium necrophorum sepsis (Lemierre's syndrome) with pulmonary septic emboli and liver abscess]. 2011 Nihon Rinsho Meneki Gakkai Kaishi pmid:22041432
Pradeep AR and Kathariya R Clarithromycin, as an adjunct to non surgical periodontal therapy for chronic periodontitis: a double blinded, placebo controlled, randomized clinical trial. 2011 Arch. Oral Biol. pmid:21529775
Mazzei T The difficulties of polytherapy: examples from antimicrobial chemotherapy. 2011 Intern Emerg Med pmid:22009620
Fujiki S et al. Stabilization mechanism of clarithromycin tablets under gastric pH conditions. 2011 Chem. Pharm. Bull. pmid:21532191
van Bijnen EM et al. The appropriateness of prescribing antibiotics in the community in Europe: study design. 2011 BMC Infect. Dis. pmid:22032233
Hwang JM et al. [A case of Menetrier's disease showing mucus bridge observed during endoscopy]. 2011 Korean J Gastroenterol pmid:21519167
Gupta V and Kalra S Choosing a gliptin. 2011 Indian J Endocrinol Metab pmid:22029001
Marshall HM et al. Mycobacterium lentiflavum in drinking water supplies, Australia. 2011 Emerging Infect. Dis. pmid:21392429
Nakahara H et al. A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment. 2011 Mod Rheumatol pmid:21484291
Francois F et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. 2011 BMC Gastroenterol pmid:21489301
Palacios-Chaves L et al. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern. 2011 PLoS ONE pmid:21249206
Bytzer P et al. Diagnosis and treatment of Helicobacter pylori infection. 2011 Dan Med Bull pmid:21466771
Jankovic M et al. A fatal Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus and concomitant Fahr's syndrome. 2011 J. Infect. Chemother. pmid:20803049
Lee BH and Kim N Quadruple or triple therapy to eradicate H pylori. 2011 Lancet pmid:21345486
Malfertheiner P et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. 2011 Lancet pmid:21345487
Atmatzidis S et al. Clarithromycin modulates immune responses in experimental peritonitis. 2011 Int. J. Antimicrob. Agents pmid:21353492
Ayala G et al. Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico. 2011 Microb. Drug Resist. pmid:21303219
Pedersen SF et al. Determination of edema in porcine coronary arteries by T2 weighted cardiovascular magnetic resonance. 2011 J Cardiovasc Magn Reson pmid:21936914
Song KH et al. Role of F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma. 2011 Gut Liver pmid:21927659
Liu G et al. Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children. 2011 Helicobacter pmid:21923681
Alkim H et al. Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. 2011 Libyan J Med pmid:21912572
Bekou V et al. Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man. 2011 BMC Dermatol. pmid:21269422
Bandettini di Poggio M et al. Clarithromycin-induced neurotoxicity in adults. 2011 J Clin Neurosci pmid:21269833
Mahachai V et al. Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test. 2011 J. Gastroenterol. Hepatol. pmid:21251064
Lee SH et al. Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates. 2011 J. Clin. Lab. Anal. pmid:21254240
Abukaraky AE et al. Antibiotics prescribing practices in oral implantology among jordanian dentists. A cross sectional, observational study. 2011 BMC Res Notes pmid:21798040
Salik D and Del Marmol V Refractory Hand Ulceration: A Case of Chronic Ulceration and Sporotrichoid Spread in a Fish Tank Hobbyist following Mycobacterium marinum Infection. 2011 Case Rep Dermatol pmid:21792350
Weese JS et al. Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: antimicrobial guidelines working group of the international society for companion animal infectious diseases. 2011 Vet Med Int pmid:21776346
Varner TR et al. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. 2011 Ann Pharmacother pmid:21775694
Luo Q et al. Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps. 2011 ORL J. Otorhinolaryngol. Relat. Spec. pmid:21757966
Gisbert JP and Calvet X Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. 2011 Aliment. Pharmacol. Ther. pmid:21745241
Dewan B and Philipose N Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial. 2011 Gastroenterol Res Pract pmid:21687618
Eruz ED et al. A case of brucellosis presenting with multiple hypodense splenic lesions and bilateral pleural effusions. 2011 Case Rep Med pmid:21687542
Zuckerman JM et al. Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). 2011 Med. Clin. North Am. pmid:21679791
Talpaert MJ et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. 2011 J. Antimicrob. Chemother. pmid:21676904
Rafii R et al. Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease. 2011 Pulm Med pmid:21660228
Feeney ER and Mallon PW HIV and HAART-Associated Dyslipidemia. 2011 Open Cardiovasc Med J pmid:21643501
Tamura T et al. Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping. 2011 Nagoya J Med Sci pmid:21614934
Liou JM et al. Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. 2011 J. Antimicrob. Chemother. pmid:21632579
Koletzko S et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. 2011 J. Pediatr. Gastroenterol. Nutr. pmid:21558964
Toros AB et al. A new modified concomitant therapy for Helicobacter pylori eradication in Turkey. 2011 Helicobacter pmid:21585608
Schmilovitz-Weiss H et al. High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients. 2011 Helicobacter pmid:21585609
Goh KL and Navaratnam P High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia. 2011 Helicobacter pmid:21585611
Kolesnikova IIu et al. [Characteristics of duodenogastric reflux in duodenal ulcer patients and its dynamics after Helicobacter pylori eradication]. 2011 Eksp Klin Gastroenterol pmid:21916229
Spurling GK et al. Antibiotics for bronchiolitis in children. 2011 Cochrane Database Syst Rev pmid:21678346
Kay MK et al. Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009. 2011 Emerging Infect. Dis. pmid:21888807
Tsoulfas G Commentary on "Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs". 2011 J. Surg. Res. pmid:21962735
Hydzik P et al. [Drug-induced erythrodermia complicated by multiorgan failure--case report]. 2011 Prz. Lek. pmid:22010450
Trzebiatowska I et al. [Psychosis caused by the treatment with clarithromycin--a case report]. 2011 Prz. Lek. pmid:22010468
Senn L et al. Does respiratory infection due to Chlamydia pneumoniae still exist? 2011 Clin. Infect. Dis. pmid:21921229
Rowland Yeo K et al. Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover. 2011 Eur J Pharm Sci pmid:21540107
Marzio L et al. Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 2011 Eur J Gastroenterol Hepatol pmid:21537122
Hagiwara N et al. In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis. 2011 J. Infect. Chemother. pmid:21710162
Matsumoto Y et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. 2011 PLoS ONE pmid:21533264
Boisson-Dupuis S et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. 2011 PLoS ONE pmid:21533230
Brittain-Long R et al. Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial. 2011 BMC Med pmid:21521505
Cavallini DC et al. Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. 2011 Lipids Health Dis pmid:21801422
Wang YC et al. In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pylori. 2011 Evid Based Complement Alternat Med pmid:19773391
Cai Y et al. Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. 2011 J. Antimicrob. Chemother. pmid:21393178
Al-Charrakh AH et al. Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis. 2011 N Am J Med Sci pmid:22540078
Zarogoulidis P et al. Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used. 2011 Int J Gen Med pmid:21403787
Drago L et al. Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae. 2011 J. Antimicrob. Chemother. pmid:21393187
Gordon Huth R et al. Mycobacterium mageritense pulmonary disease in patient with compromised immune system. 2011 Emerging Infect. Dis. pmid:21392461
Shojaei H et al. Mycobacterium novocastrense-associated pulmonary and wound infections. 2011 Emerging Infect. Dis. pmid:21392457
Vadwai V et al. Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities. 2011 PLoS ONE pmid:21935462
Dhama K et al. Tuberculosis in Birds: Insights into the Mycobacterium avium Infections. 2011 Vet Med Int pmid:21776352
Marquart ME Animal models of bacterial keratitis. 2011 J. Biomed. Biotechnol. pmid:21274270
Renaud CJ et al. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: A case series and literature review. 2011 Nephrology (Carlton) pmid:21272129
Kim JH et al. Oral azithromycin for treatment of intractable rosacea. 2011 J. Korean Med. Sci. pmid:21532865
Cong C et al. Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives. 2011 Eur J Med Chem pmid:21524827
Nadrah K and Strle F Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections. 2011 Chemother Res Pract pmid:22312555
Forrez I et al. Biogenic metals for the oxidative and reductive removal of pharmaceuticals, biocides and iodinated contrast media in a polishing membrane bioreactor. 2011 Water Res. pmid:21163512
Simoens S Factors affecting the cost effectiveness of antibiotics. 2011 Chemother Res Pract pmid:22312550
Peng X et al. Distribution pattern, behavior, and fate of antibacterials in urban aquatic environments in South China. 2011 J Environ Monit pmid:21161084